Simplex Trading LLC raised its holdings in shares of ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB – Get Rating) by 265.7% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,514 shares of the exchange traded fund's stock after buying an additional 1,100 shares during the period. Simplex Trading LLC owned about 0.08% of ProShares Ultra Nasdaq Biotechnology worth $72,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors have also recently bought and sold shares of BIB. UBS Group AG lifted its position in ProShares Ultra Nasdaq Biotechnology by 302.0% during the first quarter. UBS Group AG now owns 2,034 shares of the exchange traded fund's stock valued at $126,000 after buying an additional 1,528 shares in the last quarter. Vontobel Holding Ltd. raised its stake in shares of ProShares Ultra Nasdaq Biotechnology by 11.6% during the first quarter. Vontobel Holding Ltd. now owns 3,321 shares of the exchange traded fund's stock valued at $206,000 after purchasing an additional 344 shares during the period. Walleye Capital LLC purchased a new stake in shares of ProShares Ultra Nasdaq Biotechnology during the first quarter valued at approximately $275,000. Finally, Jane Street Group LLC purchased a new stake in shares of ProShares Ultra Nasdaq Biotechnology during the second quarter valued at approximately $290,000.
Get ProShares Ultra Nasdaq Biotechnology alerts:ProShares Ultra Nasdaq Biotechnology Trading Down 0.1 %
BIB opened at $58.75 on Wednesday. The firm's 50 day moving average is $59.70 and its 200-day moving average is $56.23. ProShares Ultra Nasdaq Biotechnology has a 52-week low of $38.42 and a 52-week high of $67.31.
ProShares Ultra Nasdaq Biotechnology Announces Dividend
The company also recently disclosed a quarterly dividend, which was paid on Friday, December 30th. Stockholders of record on Friday, December 23rd were paid a dividend of $0.02 per share. The ex-dividend date of this dividend was Thursday, December 22nd. This represents a $0.08 dividend on an annualized basis and a dividend yield of 0.14%.
About ProShares Ultra Nasdaq Biotechnology
(Get Rating)
ProShares Ultra Nasdaq Biotechnology (the Fund) seeks daily investment results, before fees and expenses, that correspond to twice (200%) the daily performance of the Index. The return of the Fund for a period longer than a single trading day will be the result of each day's returns compounded over the period, which will very likely differ from the inverse of the return of the Dow Jones United States Basic Materials Index (the Index) for that period.
Featured Articles
- Get a free copy of the StockNews.com research report on ProShares Ultra Nasdaq Biotechnology (BIB)
- LCI Industries Diversification Strategy Pays Off
- Is It Time To Buy The Dip In The Coca-Cola Company
- Ex-Dividend Date vs. Record Date: What's the Difference?
- How Does the Consumer Price Index Affect the Stock Market?
- Are Denny's Corporation Investors Due For A Grand Slam?
Want to see what other hedge funds are holding BIB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB – Get Rating).
Receive News & Ratings for ProShares Ultra Nasdaq Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ProShares Ultra Nasdaq Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.
